Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yuko Murakami-Tonami
Functional Differences Between Wild-Type and Mutant-Type BRCA1-associated Protein 1 Tumor Suppressor Against Malignant Mesothelioma Cells
Cancer Science
Cancer Research
Medicine
Oncology
Related publications
LATS2 Is a Tumor Suppressor Gene of Malignant Mesothelioma
Cancer Research
Cancer Research
Oncology
Structural Differences Between Wild-Type and Double Mutant EGFR Modulated by Third-Generation Kinase Inhibitors
Journal of the American Chemical Society
Biochemistry
Colloid
Catalysis
Chemistry
Surface Chemistry
Table 2: Altered Protein Expression Between B. Pseudomallei Wild-Type K96243 and the SDO Mutant.
Susceptibility to Radiation Induced Apoptosis and Senescence in P53 Wild Type and P53 Mutant Breast Tumor Cells
Differences in the Risk Factors Associated With Diabetic Retinopathy Between Type 1 and Type 2 Diabetes Mellitus
Endocrine Abstracts
Degradation of Overexpressed Wild-Type and Mutant Uricase Proteins in Cultured Cells
Journal of Histochemistry and Cytochemistry
Anatomy
Histology
Radioimmunotargeting of Malignant Glioma by Monoclonal Antibody D2C7 Reactive Against Both Wild-Type and Variant III Mutant Epidermal Growth Factor Receptors
Nuclear Medicine and Biology
Cancer Research
Nuclear Medicine
Radiology
Molecular Medicine
Imaging
The Human Tumor Suppressor ARF Interacts With Spinophilin/Neurabin II, a Type 1 Protein-Phosphatase-Binding Protein
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
A Farnesyl-Protein Transferase Inhibitor Induces P21 Expression and G1Block in P53 Wild Type Tumor Cells
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
